-+ 0.00%
-+ 0.00%
-+ 0.00%

Ladenburg Thalmann Maintains Buy on Alpha Tau Medical, Raises Price Target to $14

Benzinga·05/12/2026 22:25:16
Listen to the news
Ladenburg Thalmann analyst Jeff Cohen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $12 to $14.